Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Assay and Drug Development Technologies
|
April 20, 2004
Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays
Terry L Riss, Richard A Moravec
Expert Opinion on Drug Discovery
|
March 20, 2013
Update on in vitro cytotoxicity assays for drug development
Andrew L Niles, Richard A Moravec, Terry L Riss
Current Chemical Genomics
|
February 18, 2010
In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2011
Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death
Terry L Riss, Richard A Moravec, Andrew L Niles
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Caspase activity assays
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Multiplex caspase activity and cytotoxicity assays
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
October 14, 2014
Homogeneous, bioluminescent proteasome assays
Martha A O'Brien, Richard A Moravec, Terry L Riss, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
September 17, 2021
Treating Cells as Reagents to Design Reproducible Assays
Terry L Riss, Richard A Moravec, Sarah J Duellman, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Homogeneous, bioluminescent proteasome assays
Martha A O'Brien, Richard A Moravec, Terry L Riss, et al.
Analytical Biochemistry
|
May 21, 2009
Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format
Richard A Moravec, Martha A O'Brien, William J Daily, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Assay and Drug Development Technologies
|
April 20, 2004
Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays
Terry L Riss, Richard A Moravec
Expert Opinion on Drug Discovery
|
March 20, 2013
Update on in vitro cytotoxicity assays for drug development
Andrew L Niles, Richard A Moravec, Terry L Riss
Current Chemical Genomics
|
February 18, 2010
In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
April 7, 2011
Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death
Terry L Riss, Richard A Moravec, Andrew L Niles
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Caspase activity assays
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Multiplex caspase activity and cytotoxicity assays
Andrew L Niles, Richard A Moravec, Terry L Riss
Methods in Molecular Biology (Clifton, N.J.)
|
October 14, 2014
Homogeneous, bioluminescent proteasome assays
Martha A O'Brien, Richard A Moravec, Terry L Riss, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
September 17, 2021
Treating Cells as Reagents to Design Reproducible Assays
Terry L Riss, Richard A Moravec, Sarah J Duellman, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 8, 2008
Homogeneous, bioluminescent proteasome assays
Martha A O'Brien, Richard A Moravec, Terry L Riss, et al.
Analytical Biochemistry
|
May 21, 2009
Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format
Richard A Moravec, Martha A O'Brien, William J Daily, et al.
Page
of 2